| Appearance | White to Almost white powder to crystal |
| Purity(HPLC)(CAD) | min. 97.0 area% |
| Specific rotation | +27.0 to +29.0 deg (C=0.5, CHCl3) |
| Melting point | 208.0 to 212.0 °C |
| Solubility | Soluble in Ether, Benzene |
Active Pharmaceutical Ingredients
Lupeol
20(29)-Lupen-3β-ol; 3β-Hydroxy-20(29)-lupene; Fagarasterol; Lup-20(29)-en-3β-ol; (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-Hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol
| Purity / Analysis Method | >97.0%(HPLC) |
| Molecular Formula / Molecular Weight | C30H50O = 426.73 |
| Storage Temperature | 0-10°C |
| CAS RN | 545-47-1 |
| Unit | Price |
| 5 mg | 4500 |
| 10 mg | 7500 |
| 25 mg | 8800 |
| Note | •Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
